ROSEN Law Firm Files Class Action Lawsuit Against SolarEdge Technologies, Inc. December 16, 2023 (GLOBE NEWSWIRE) — NEW YORK ROSEN Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of purchasers of securities of SolarEdge Technologies, Inc. (NASDAQ: SEDG) between February 22, 2022, and October…
Else Nutrition Holdings Inc. (OTCQX:BABYF) Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ET Welcome to the Else Nutrition’s Third Quarter 2024 Earnings Call. Today, we will be discussing the financial performance of Else Nutrition Holdings Inc. for the third quarter of 2024. We are pleased to have you join us for this…
Many tech stocks surged to record highs over the past year amid hopes for deeper interest rate cuts and an improved macroeconomic environment. The Tech Stock Boom: Finding Value in a Volatile Market Over the past year, the tech sector has experienced a monumental surge in stock prices, with many companies reaching record highs. This…
The Schall Law Firm Files Class Action Lawsuit Against Kyverna Therapeutics, Inc. Overview LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, has announced that the firm has filed a class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or “the Company”) (NASDAQ:KYTX) for…
Welcome to the Abpro Holdings, Inc. Blog! Exciting News: Abpro Celebrates Business Combination and Financing WOBURN, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Abpro Holdings, Inc. (Nasdaq:ABP) (“Abpro”), a biotech company with the mission of improving the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies, recently made headlines for celebrating the…
Hydrogen Power: The Next Frontier in Economic Growth The Rise and Fall of the Hydrogen Power Sector For years, the hydrogen power sector has been hailed as the next big thing in green technology. Following China’s remarkable success with electric vehicles, lithium batteries, and solar cells, many believed that hydrogen power would be the key…
Welcome to the Future of CML Treatment! The latest news from Novartis Basel, December 8, 2024 Novartis has just released groundbreaking results from the Phase III ASC4FIRST trial, showcasing the superior efficacy of Scemblix® (asciminib) in treating Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) patients. The study compared Scemblix to standard-of-care tyrosine…
Welcome to the Big Apple! Exploring the Streets of New York City There’s something magical about the hustle and bustle of New York City. The energy is palpable as you walk through the crowded streets, surrounded by skyscrapers that seem to touch the clouds. From Times Square to Central Park, every corner of this city…
